Affymax, Inc.
Affymax, Inc. (AFFY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AFFY · as of Jun 9, 2026
Key Statistics
Explore Affymax, Inc. Data
affy stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 12.5%
Competitors & Peers
affy competitorsAFFY
AMBS
BSSP
CNBX
ENDV
GNLKQStock Performance
Full HistoryAbout Affymax, Inc.
Affymax, Inc. presently lacks any substantial operational activities. In its earlier history, the firm concentrated on the creation of pharmaceutical agents designed to improve therapies for severe an…
what is affymax, inc. · affy stock overview · affymax, inc. company profile · who is affymax, inc. ceo · affy OTC · affymax, inc. headquarters · affymax, inc. business segments
About Stock Overview & Key Data
Affymax, Inc. (AFFY) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 15, 2006. As of the latest trading session, AFFY stock price is $0.00, with a market capitalization of $37,490. The stock has returned +900.00% over the past 12 months and +25.00% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Affymax, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2013, Affymax, Inc. reported revenue of $1.4M and net income of -$14.4M. For detailed data — including Affymax, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Affymax, Inc. (AFFY) stock price is $0.00. The stock is traded on OTC under the ticker symbol AFFY. The 52-week range is $0.00 – $0.00.